Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-08

AUTHORS

Jyoti Velayudhan, Yuh-feng Chen, Amanda Rohrbach, Christina Pastula, Gwen Maher, Heather Thomas, Ryan Brown, Teresa L. Born

ABSTRACT

BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity. OBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP 501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity. METHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor α (TNFα) and relative binding to transmembrane TNFα. The neutralization of TNFα-induced caspase activation, TNFα- and lymphotoxin-α (LTα)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors FcγRIa, FcγRIIa (131H), FcγRIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity. RESULTS: The data demonstrate that ABP 501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities. CONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP 501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP 501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar. More... »

PAGES

339-351

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2

DOI

http://dx.doi.org/10.1007/s40259-016-0185-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042463549

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27422671


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adalimumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody-Dependent Cell Cytotoxicity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biosimilar Pharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CHO Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cricetulus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility Antigens Class I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphotoxin-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Fc", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, IgG", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surface Plasmon Resonance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velayudhan", 
        "givenName": "Jyoti", 
        "id": "sg:person.01332245460.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332245460.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Yuh-feng", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rohrbach", 
        "givenName": "Amanda", 
        "id": "sg:person.010407272255.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010407272255.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pastula", 
        "givenName": "Christina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maher", 
        "givenName": "Gwen", 
        "id": "sg:person.01367737005.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367737005.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thomas", 
        "givenName": "Heather", 
        "id": "sg:person.01307711153.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307711153.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Ryan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Born", 
        "givenName": "Teresa L.", 
        "id": "sg:person.014172554655.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014172554655.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.crohns.2014.02.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001979414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/bs.s75573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004115169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2014.10.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009055890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/abio.2001.5380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010553021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.1003526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011527870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2804", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011803907", 
          "https://doi.org/10.1038/nrd2804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-06-583617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011903836"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/abb.2013.44a004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022030812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biologicals.2014.05.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027312444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mib.0b013e318281333b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029263183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mib.0b013e318281333b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029263183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jidsymp.5650034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038176817", 
          "https://doi.org/10.1038/sj.jidsymp.5650034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40259-016-0184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038300105", 
          "https://doi.org/10.1007/s40259-016-0184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40259-016-0184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038300105", 
          "https://doi.org/10.1007/s40259-016-0184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1074-7613(00)80152-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040583975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.23447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041038096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaad.2016.02.972", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041679936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2014-eular.2166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041998525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cyto.2008.11.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044711621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pharmthera.2007.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045852057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/apt.12749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046366682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keq031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046888240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/blr.2006.25.447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059238419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062759425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062759425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078459400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078459400"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08", 
    "datePublishedReg": "2016-08-01", 
    "description": "BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity.\nOBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP\u00a0501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity.\nMETHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor \u03b1 (TNF\u03b1) and relative binding to transmembrane TNF\u03b1. The neutralization of TNF\u03b1-induced caspase activation, TNF\u03b1- and lymphotoxin-\u03b1 (LT\u03b1)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors Fc\u03b3RIa, Fc\u03b3RIIa (131H), Fc\u03b3RIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.\nRESULTS: The data demonstrate that ABP\u00a0501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities.\nCONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP\u00a0501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP\u00a0501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40259-016-0185-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1111842", 
        "issn": [
          "1173-8804", 
          "1179-190X"
        ], 
        "name": "BioDrugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab", 
    "pagination": "339-351", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ca45ff14dab230c932c2e0bbde1e12d38352961b3b89bdeb3c3d104006af08d3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27422671"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9705305"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40259-016-0185-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042463549"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40259-016-0185-2", 
      "https://app.dimensions.ai/details/publication/pub.1042463549"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70027_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40259-016-0185-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      66 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40259-016-0185-2 schema:about N07d10780aeb744069c780dc027e1df8f
2 N506290d4196b45f0a16db609d7d28298
3 N50cbfa67cc7c4759a7d2feab1ad5e838
4 N569c75489f2b4a669d0a19a3f113f4c3
5 N5bd8eed50af249f19189b2bb3c78daa8
6 N68450ed714ae4dd7aa120a0f88f45db8
7 N6f2b10be6d88430ebe15f7f3e3a8e512
8 N7220d5332dda4a2fa6a1c18b1a837373
9 N94ef4911789645f696eb47426263573a
10 Nb52e46cc73d0480ab5e80b1d4756ef1e
11 Nd3a6d2e6758544e1b31b800224f84330
12 Neb0a34bd8e094dc1b3e6f9ce46d174b7
13 Nf99934611f3d4a39868660984eab19e6
14 anzsrc-for:11
15 anzsrc-for:1107
16 schema:author N1811482bfd634752ad63bdba602a7372
17 schema:citation sg:pub.10.1007/s40259-016-0184-3
18 sg:pub.10.1038/nrd2804
19 sg:pub.10.1038/sj.jidsymp.5650034
20 https://doi.org/10.1002/art.23447
21 https://doi.org/10.1002/ibd.20225
22 https://doi.org/10.1006/abio.2001.5380
23 https://doi.org/10.1016/j.biologicals.2014.05.005
24 https://doi.org/10.1016/j.crohns.2014.02.007
25 https://doi.org/10.1016/j.cyto.2008.11.008
26 https://doi.org/10.1016/j.jaad.2016.02.972
27 https://doi.org/10.1016/j.pharmthera.2007.10.001
28 https://doi.org/10.1016/s1074-7613(00)80152-1
29 https://doi.org/10.1053/j.gastro.2014.10.011
30 https://doi.org/10.1089/blr.2006.25.447
31 https://doi.org/10.1093/rheumatology/keq031
32 https://doi.org/10.1097/mib.0b013e318281333b
33 https://doi.org/10.1111/apt.12749
34 https://doi.org/10.1136/annrheumdis-2014-eular.2166
35 https://doi.org/10.1136/annrheumdis-2015-208914
36 https://doi.org/10.1182/blood-2014-06-583617
37 https://doi.org/10.2147/bs.s75573
38 https://doi.org/10.4049/jimmunol.1003526
39 https://doi.org/10.4236/abb.2013.44a004
40 https://doi.org/10.6004/jnccn.2011.0136
41 schema:datePublished 2016-08
42 schema:datePublishedReg 2016-08-01
43 schema:description BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity. OBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP 501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity. METHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor α (TNFα) and relative binding to transmembrane TNFα. The neutralization of TNFα-induced caspase activation, TNFα- and lymphotoxin-α (LTα)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors FcγRIa, FcγRIIa (131H), FcγRIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity. RESULTS: The data demonstrate that ABP 501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities. CONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP 501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP 501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf N337c6344bd364d2f9002de0e994a0dc4
48 Ne499704064cd4480964c7d5e6d40dfeb
49 sg:journal.1111842
50 schema:name Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
51 schema:pagination 339-351
52 schema:productId N0557cbf0dda240a9bb2158bafd7fbc1c
53 N10f92da6125a4733b564fc56de97e551
54 N477852d4594046e2944edac5ac7ec1f8
55 N4ace8a91c8aa455aaf721883e10b67b3
56 Na0960b51c2a0462e8391d5d19a455c0d
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042463549
58 https://doi.org/10.1007/s40259-016-0185-2
59 schema:sdDatePublished 2019-04-11T12:35
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Ncceb75386b8f4fb58188c33864e03c15
62 schema:url https://link.springer.com/10.1007%2Fs40259-016-0185-2
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N0557cbf0dda240a9bb2158bafd7fbc1c schema:name nlm_unique_id
67 schema:value 9705305
68 rdf:type schema:PropertyValue
69 N07d10780aeb744069c780dc027e1df8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Surface Plasmon Resonance
71 rdf:type schema:DefinedTerm
72 N10f92da6125a4733b564fc56de97e551 schema:name doi
73 schema:value 10.1007/s40259-016-0185-2
74 rdf:type schema:PropertyValue
75 N1811482bfd634752ad63bdba602a7372 rdf:first sg:person.01332245460.17
76 rdf:rest N6cd692511e3d4e519dcf4c8c8bef381d
77 N1bd8d2f7365c46bca7969115cd4ac498 rdf:first sg:person.01307711153.47
78 rdf:rest N594cfa5d9fc4436bb4c8cfc51fb029ea
79 N27a880c8e399422aa7580dbdf23f09fb rdf:first N6b6b062fcf614166a058f705bdc5e247
80 rdf:rest N480266527cb944c081752f141da6d2ab
81 N337c6344bd364d2f9002de0e994a0dc4 schema:issueNumber 4
82 rdf:type schema:PublicationIssue
83 N477852d4594046e2944edac5ac7ec1f8 schema:name dimensions_id
84 schema:value pub.1042463549
85 rdf:type schema:PropertyValue
86 N480266527cb944c081752f141da6d2ab rdf:first sg:person.01367737005.73
87 rdf:rest N1bd8d2f7365c46bca7969115cd4ac498
88 N4ace8a91c8aa455aaf721883e10b67b3 schema:name readcube_id
89 schema:value ca45ff14dab230c932c2e0bbde1e12d38352961b3b89bdeb3c3d104006af08d3
90 rdf:type schema:PropertyValue
91 N506290d4196b45f0a16db609d7d28298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Receptors, IgG
93 rdf:type schema:DefinedTerm
94 N50cbfa67cc7c4759a7d2feab1ad5e838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 N569c75489f2b4a669d0a19a3f113f4c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Receptors, Fc
99 rdf:type schema:DefinedTerm
100 N594cfa5d9fc4436bb4c8cfc51fb029ea rdf:first Na5d8ec355b2f45368bf98c7aa6f71f15
101 rdf:rest N6837f838c9484746b302b0ecb951c6fa
102 N5bd8eed50af249f19189b2bb3c78daa8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Animals
104 rdf:type schema:DefinedTerm
105 N6837f838c9484746b302b0ecb951c6fa rdf:first sg:person.014172554655.08
106 rdf:rest rdf:nil
107 N68450ed714ae4dd7aa120a0f88f45db8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name CHO Cells
109 rdf:type schema:DefinedTerm
110 N6b6b062fcf614166a058f705bdc5e247 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
111 schema:familyName Pastula
112 schema:givenName Christina
113 rdf:type schema:Person
114 N6cd692511e3d4e519dcf4c8c8bef381d rdf:first Nd7d57c9576fa485ca0042f85f4464d28
115 rdf:rest Ndd44bcc550ec4d57826ced75b3951966
116 N6f2b10be6d88430ebe15f7f3e3a8e512 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Antibody-Dependent Cell Cytotoxicity
118 rdf:type schema:DefinedTerm
119 N7220d5332dda4a2fa6a1c18b1a837373 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Histocompatibility Antigens Class I
121 rdf:type schema:DefinedTerm
122 N94ef4911789645f696eb47426263573a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Tumor Necrosis Factor-alpha
124 rdf:type schema:DefinedTerm
125 Na0960b51c2a0462e8391d5d19a455c0d schema:name pubmed_id
126 schema:value 27422671
127 rdf:type schema:PropertyValue
128 Na5d8ec355b2f45368bf98c7aa6f71f15 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
129 schema:familyName Brown
130 schema:givenName Ryan
131 rdf:type schema:Person
132 Nb52e46cc73d0480ab5e80b1d4756ef1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Lymphotoxin-alpha
134 rdf:type schema:DefinedTerm
135 Ncceb75386b8f4fb58188c33864e03c15 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Nd3a6d2e6758544e1b31b800224f84330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Biosimilar Pharmaceuticals
139 rdf:type schema:DefinedTerm
140 Nd7d57c9576fa485ca0042f85f4464d28 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
141 schema:familyName Chen
142 schema:givenName Yuh-feng
143 rdf:type schema:Person
144 Ndd44bcc550ec4d57826ced75b3951966 rdf:first sg:person.010407272255.81
145 rdf:rest N27a880c8e399422aa7580dbdf23f09fb
146 Ne499704064cd4480964c7d5e6d40dfeb schema:volumeNumber 30
147 rdf:type schema:PublicationVolume
148 Neb0a34bd8e094dc1b3e6f9ce46d174b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Adalimumab
150 rdf:type schema:DefinedTerm
151 Nf99934611f3d4a39868660984eab19e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Cricetulus
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
158 schema:name Immunology
159 rdf:type schema:DefinedTerm
160 sg:journal.1111842 schema:issn 1173-8804
161 1179-190X
162 schema:name BioDrugs
163 rdf:type schema:Periodical
164 sg:person.010407272255.81 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
165 schema:familyName Rohrbach
166 schema:givenName Amanda
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010407272255.81
168 rdf:type schema:Person
169 sg:person.01307711153.47 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
170 schema:familyName Thomas
171 schema:givenName Heather
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307711153.47
173 rdf:type schema:Person
174 sg:person.01332245460.17 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
175 schema:familyName Velayudhan
176 schema:givenName Jyoti
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332245460.17
178 rdf:type schema:Person
179 sg:person.01367737005.73 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
180 schema:familyName Maher
181 schema:givenName Gwen
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367737005.73
183 rdf:type schema:Person
184 sg:person.014172554655.08 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
185 schema:familyName Born
186 schema:givenName Teresa L.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014172554655.08
188 rdf:type schema:Person
189 sg:pub.10.1007/s40259-016-0184-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038300105
190 https://doi.org/10.1007/s40259-016-0184-3
191 rdf:type schema:CreativeWork
192 sg:pub.10.1038/nrd2804 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011803907
193 https://doi.org/10.1038/nrd2804
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/sj.jidsymp.5650034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038176817
196 https://doi.org/10.1038/sj.jidsymp.5650034
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/art.23447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041038096
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1002/ibd.20225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023972012
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1006/abio.2001.5380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010553021
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.biologicals.2014.05.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027312444
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.crohns.2014.02.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001979414
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.cyto.2008.11.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044711621
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.jaad.2016.02.972 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041679936
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/j.pharmthera.2007.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045852057
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s1074-7613(00)80152-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040583975
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1053/j.gastro.2014.10.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009055890
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1089/blr.2006.25.447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059238419
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/rheumatology/keq031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046888240
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/mib.0b013e318281333b schema:sameAs https://app.dimensions.ai/details/publication/pub.1029263183
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1111/apt.12749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046366682
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/annrheumdis-2014-eular.2166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041998525
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1136/annrheumdis-2015-208914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062759425
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1182/blood-2014-06-583617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011903836
231 rdf:type schema:CreativeWork
232 https://doi.org/10.2147/bs.s75573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004115169
233 rdf:type schema:CreativeWork
234 https://doi.org/10.4049/jimmunol.1003526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011527870
235 rdf:type schema:CreativeWork
236 https://doi.org/10.4236/abb.2013.44a004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022030812
237 rdf:type schema:CreativeWork
238 https://doi.org/10.6004/jnccn.2011.0136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078459400
239 rdf:type schema:CreativeWork
240 https://www.grid.ac/institutes/grid.417886.4 schema:alternateName Amgen (United States)
241 schema:name Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...